 "GSK puts Mumbai land on the block again")
The company invited bids for its land parcel recently, said a source. The land parcel is valued between Rs 1400 crore and Rs 1800 crore, said a television channel report today.
"The company has been considering options for divestment of its land at Thane. However to date, the company has not shortlisted any buyer or entered into sale agreement on the divestment of the land at Thane. The company will keep the Stock Exchange informed in the event the company makes a decision regarding entering into a binding agreement for divestment of its land at Thane." the company said.
GSK had tried to sell the land in 2014 but the plans fell through because of legal hurdles.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app